Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is Honig, Lawrence S  [Clear All Filters]
Journal Article
L. Tariciotti, Casadei, M., Honig, L. S., Teich, A. F., Ii, G. M. McKhann, Tosto, G., and Mayeux, R., Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia., J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
S. P. Salloway, Sperling, R., Fox, N. C., Sabbagh, M. N., Honig, L. S., Porsteinsson, A. P., Rofael, H., Ketter, N., Wang, D., Liu, E., Carr, S., Black, R. S., and H Brashear, R., Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study., J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
W. Gulisano, Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O., Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade., J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.